Journal of Clinical Oncology
Oncologists generally refer to specialized palliative care late
(HealthDay)—Definitional issues and non-acceptance of patients receiving chemotherapy are the barriers to earlier referral to specialized palliative care (SPC) by oncologists, according to a study published ...
Cancer
Oct 30, 2012 |
not rated yet |
0
More intensive chemo ups survival in ewing sarcoma
(HealthDay)—More intensive chemotherapy (every two weeks versus every three weeks) improves event-free survival for patients with localized Ewing sarcoma, according to a study published online Oct. 22 in the Journal of ...
Cancer
Oct 29, 2012 |
not rated yet |
0
Older breast cancer patients see more complications with brachytherapy
heralded for its low complication rates—actually results in more complications than whole-breast radiation one year after treatment, Yale School of Medicine researchers report in the October issue of the Journal of Clinical On ...
Cancer
Oct 22, 2012 |
not rated yet |
0
|
Social outcomes good for most pediatric brain tumor survivors
(HealthDay)—While the majority of survivors of pediatric embryonal tumors display positive social outcomes several years after diagnosis and treatment, specific risk factors may affect social adjustment ...
Cancer
Oct 21, 2012 |
not rated yet |
0
Lexatumumab tolerated for pediatric solid tumors
(HealthDay)—Lexatumumab, an agonistic, full human monoclonal antibody against tumor necrosis factor-related apoptosis-inducing ligand receptor 2, is well tolerated and may lessen certain clinical symptoms ...
Cancer
Oct 16, 2012 |
5 / 5 (1) |
0
Patient-reported outcomes essential to comparative effectiveness research
Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.
Cancer
Oct 16, 2012 |
not rated yet |
0
Gene signature validated for oral cancer metastases
(HealthDay)—A multigene signature effectively predicts the presence of lymph node metastases in squamous cell carcinoma of the oral cavity (OSCC) and oropharynx (OPSCC), according to a study published online ...
Cancer
Oct 14, 2012 |
not rated yet |
0
HIV status doesn't influence Hodgkin's lymphoma outcome
(HealthDay)—Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, ...
Cancer
Oct 11, 2012 |
not rated yet |
0
Interventions helpful for breast cancer-induced menopause
(HealthDay)—Cognitive behavioral therapy (CBT) and physical exercise improve endocrine and urinary symptoms as well as physical functioning in patients with breast cancer treatment-induced menopause, according ...
Cancer
Oct 11, 2012 |
not rated yet |
0
BMI and lean body mass decline after allogeneic HSCT
(HealthDay)—In survivors of childhood hematologic malignancies who have received allogeneic hematopoietic stem cell transplantation (alloHSCT), body mass index (BMI) decreases significantly, mainly due ...
Cancer
Oct 04, 2012 |
2 / 5 (1) |
0
Short-, long-course therapy comparable in T3 rectal cancer
(HealthDay)—There are no statistically significant differences in the rates of local recurrence (LR), distant recurrence, relapse-free survival, overall survival, or late toxicity in patients treated with ...
Cancer
Sep 27, 2012 |
not rated yet |
0
Watch-and-wait OK in low-tumor burden follicular lymphoma
(HealthDay)—An initial watch-and-wait strategy does not have a detrimental effect on the freedom from treatment failure (FFTF) or overall survival rate in selected patients with low-tumor burden follicular ...
Cancer
Sep 26, 2012 |
5 / 5 (1) |
0
Ketamine—an established cancer-pain drug—may do more harm than good
(Medical Xpress)—A drug which for decades has been widely used to treat pain related to cancer has no net clinical benefit, researchers in the Palliative Care Clinical Studies Collaborative (PaCCSC) based ...
Cancer
Sep 25, 2012 |
3.7 / 5 (3) |
0
New guidelines issued for pediatric fever and neutropenia
(HealthDay)—New evidence-based guidelines have been compiled on the management of fever and and neutropenia (FN) in children with cancer and/or who are undergoing hematopoietic stem-cell transplantation; ...
Cancer
Sep 19, 2012 |
not rated yet |
0
L-carnitine does not reduce cancer-related fatigue
(HealthDay)—Patients with invasive malignancies who take L-carnitine supplements do not experience a reduction in fatigue, pain, or depression, according to research published online Sept. 17 in the Journal of ...
Cancer
Sep 18, 2012 |
not rated yet |
0
